SK Biopharmaceuticals said Thursday it joined the Pharmaceutical Supply Chain Initiative (PSCI), the first Korean company to do so.
Daewoong Pharmaceutical won approval to start Phase 3 clinical trials of Enavogliflozin, a diabetes treatment, from regulators in China.
The Korea Pharmaceutical and Bio-pharma Manufacturers Association (Kpbma), Basel Area Business and Innovation and its biotech accelerator BaseLaunch signed an agreement at the Swiss Embassy in Seoul on Monday to establish tailored...
Hanmi Pharmaceutical is expected to receive U.S. Food and Drug Administration (FDA) marketing approvals for two new drugs this year, CEO Kwon Se-chang said during the 40th annual J.P. Morgan HealthCare Conference.
JW1601, an oral atopy treatment candidate that was licensed by JW Pharmaceutical to Ballerup, Denmark-based Leo Pharma began Phase 2 clinical trials, the Korean company said Wednesday.
Ildong Pharmaceutical signed an agreement with Osaka's Shionogi to codevelop S-217622, an oral Covid-19 treatment candidate.
Daewoong Pharmaceutical said Monday it will supply Vietnamese pharmaceutical company Vietha Pharma Covid-19 diagnostic kits in a deal potentially worth 12 billion won ($10.2 million).
Dong-A Pharmaceutical, Dong-A Socio Holdings’ pharmaceutical arm, and the logistics subsidiary Yongma Logis signed a memorandum of understanding (MOU) with Korean Pharmaceutical Association (KPA) for a joint project to collect...
Daewoong Pharmaceutical signed a deal potentially worth 99.1 billion won ($83.7 million) with Aghrass Healthcare Limited to license its Fexuprazan gastroesophageal reflux treatment.
Dong-A Pharmaceutical is boosting the price of Bacchus, Korea’s most relied-upon energy drink, for the first time in more than six and a half years.
Korea JoongAng Daily Sitemap
